In A549 non‐small cell lung cancer (NSCLC) cells, overexpression of FBXO22 increases cell proliferation via the promotion of cyclin‐dependent kinase 4 protein levels and the regulation of phosphatase and tensin homologue (PTEN).18 Here, FBXO22 is linked to non-small cell lung carcinoma.